NHERF1/EBP50 gene mutations were identified in cancer cells [33], in addition knockdown of EBP50 increased cellular proliferation and migration of cancer cell lines suggesting that EBP50 acts as a tumor suppressor [34]. This evidence concerns the gene NHERF1 and neoplasm.